These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27590157)

  • 21. Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand-Addicted Pancreatic Cancer.
    Aguilera KY; Le T; Riahi R; Lay AR; Hinz S; Saadat EA; Vashisht AA; Wohlschlegel J; Donahue TR; Radu CG; Dawson DW
    Mol Cancer Ther; 2022 Jun; 21(6):936-947. PubMed ID: 35313331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the 'reversed' amide scaffold.
    Xu Z; Xu X; O'Laoi R; Ma H; Zheng J; Chen S; Luo L; Hu Z; He S; Li J; Zhang H; Zhang X
    Bioorg Med Chem; 2016 Nov; 24(22):5861-5872. PubMed ID: 27692509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental inhibition of porcupine-mediated Wnt O-acylation attenuates kidney fibrosis.
    Madan B; Patel MB; Zhang J; Bunte RM; Rudemiller NP; Griffiths R; Virshup DM; Crowley SD
    Kidney Int; 2016 May; 89(5):1062-1074. PubMed ID: 27083283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor.
    Ma H; Chen Q; Zhu F; Zheng J; Li J; Zhang H; Chen S; Xing H; Luo L; Zheng LT; He S; Zhang X
    Eur J Med Chem; 2018 Apr; 149():110-121. PubMed ID: 29499483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell biology. The unusual case of Porcupine.
    Lum L; Clevers H
    Science; 2012 Aug; 337(6097):922-3. PubMed ID: 22923569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Wnt inhibitor LGK-974 enhances radiosensitivity of HepG2 cells by modulating Nrf2 signaling.
    Tian D; Shi Y; Chen D; Liu Q; Fan F
    Int J Oncol; 2017 Aug; 51(2):545-554. PubMed ID: 28627706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Porcupine-dependent Wnt activity within the uterine epithelium is essential for fertility.
    Farah O; Biechele S; Rossant J; Dufort D
    Biol Reprod; 2017 Nov; 97(5):688-697. PubMed ID: 29036275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3-mutant neoplasia.
    Koo BK; van Es JH; van den Born M; Clevers H
    Proc Natl Acad Sci U S A; 2015 Jun; 112(24):7548-50. PubMed ID: 26023187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacophore Model for Wnt/Porcupine Inhibitors and Its Use in Drug Design.
    Poulsen A; Ho SY; Wang W; Alam J; Jeyaraj DA; Ang SH; Tan ES; Lin GR; Cheong VW; Ke Z; Lee MA; Keller TH
    J Chem Inf Model; 2015 Jul; 55(7):1435-48. PubMed ID: 26024410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of RSPO2 Fusion Mutations and Target Therapy Using a Porcupine Inhibitor.
    Li C; Cao J; Zhang N; Tu M; Xu F; Wei S; Chen X; Xu Y
    Sci Rep; 2018 Sep; 8(1):14244. PubMed ID: 30250044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. R-Spondin chromosome rearrangements drive Wnt-dependent tumour initiation and maintenance in the intestine.
    Han T; Schatoff EM; Murphy C; Zafra MP; Wilkinson JE; Elemento O; Dow LE
    Nat Commun; 2017 Jul; 8():15945. PubMed ID: 28695896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scaffold Hopping and Optimization of Maleimide Based Porcupine Inhibitors.
    Ho SY; Alam J; Jeyaraj DA; Wang W; Lin GR; Ang SH; Tan ESW; Lee MA; Ke Z; Madan B; Virshup DM; Ding LJ; Manoharan V; Chew YS; Low CB; Pendharkar V; Sangthongpitag K; Hill J; Keller TH; Poulsen A
    J Med Chem; 2017 Aug; 60(15):6678-6692. PubMed ID: 28671458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetically engineered mouse models to evaluate the role of Wnt secretion in bone development and homeostasis.
    Williams BO
    Am J Med Genet C Semin Med Genet; 2016 Mar; 172C(1):24-6. PubMed ID: 26818176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer.
    Proffitt KD; Madan B; Ke Z; Pendharkar V; Ding L; Lee MA; Hannoush RN; Virshup DM
    Cancer Res; 2013 Jan; 73(2):502-7. PubMed ID: 23188502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological inhibition of porcupine induces regression of experimental skin fibrosis by targeting Wnt signalling.
    Chen CW; Beyer C; Liu J; Maier C; Li C; Trinh-Minh T; Xu X; Cole SH; Hsieh MH; Ng N; Althage A; Meeusen S; Pan S; Svensson EC; Seidel HM; Schett G; Gergely P; Harris JL; Distler JH
    Ann Rheum Dis; 2017 Apr; 76(4):773-778. PubMed ID: 28153829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Wnt addiction of genetically defined cancers reversed by PORCN inhibition.
    Madan B; Ke Z; Harmston N; Ho SY; Frois AO; Alam J; Jeyaraj DA; Pendharkar V; Ghosh K; Virshup IH; Manoharan V; Ong EH; Sangthongpitag K; Hill J; Petretto E; Keller TH; Lee MA; Matter A; Virshup DM
    Oncogene; 2016 Apr; 35(17):2197-207. PubMed ID: 26257057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porcupine-mediated lipid-modification regulates the activity and distribution of Wnt proteins in the chick neural tube.
    Galli LM; Barnes TL; Secrest SS; Kadowaki T; Burrus LW
    Development; 2007 Sep; 134(18):3339-48. PubMed ID: 17720697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Porcupine-dependent Wnt signaling controls stromal proliferation and endometrial gland maintenance through the action of distinct WNTs.
    Farah O; Biechele S; Rossant J; Dufort D
    Dev Biol; 2017 Feb; 422(1):58-69. PubMed ID: 27965056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pan-PI3K inhibitor GDC-0941 activates canonical WNT signaling to confer resistance in TNBC cells: resistance reversal with WNT inhibitor.
    Tzeng HE; Yang L; Chen K; Wang Y; Liu YR; Pan SL; Gaur S; Hu S; Yen Y
    Oncotarget; 2015 May; 6(13):11061-73. PubMed ID: 25857298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells.
    Kahlert UD; Suwala AK; Koch K; Natsumeda M; Orr BA; Hayashi M; Maciaczyk J; Eberhart CG
    J Neuropathol Exp Neurol; 2015 Sep; 74(9):889-900. PubMed ID: 26222502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.